Neopharm Reports Operating Profit of 3.6 Billion KRW in 3Q, Down 28.1% Year-on-Year

[Asia Economy Reporter Kang Nahum] Neopharm announced on the 6th that its consolidated operating profit for the third quarter of this year was preliminarily estimated at 3.6 billion KRW, a 28.1% decrease compared to the same period last year.

Sales amounted to 17.9 billion KRW, down 6.3% from the same period last year, and net profit decreased by 28.8% to 3 billion KRW.